Daniel Brennan

Michael Ryskin

Ryan MacDonald

Andrew Brackmann

Tejas Savant

Daniel Arias

David Westenberg

Mark Massaro

Rachel Vatnsdal

Rachel Vatnsdal Olson

Subhalaxmi Nambi

Dan Arias

Douglas Schenkel

Doug Schenkel

Mark [indiscernible]

Mark Schappel

Subbu Nambi

Yuko Oku

- **Tempus AI** has been **selected by the Advanced Research Projects Agency for Health (ARPA-H)** to provide **contract research organization (CRO) and testing services** for the agency's **ADAPT program**.  **[1717115_54548193252544e1abe35b0fc23f9ad9_0]** 
- The **ADAPT program** aims to **revolutionize cancer treatment** by developing adaptive strategies that leverage biomarkers to target metastatic non-small cell lung, breast, and colorectal cancers, with the ultimate goal of **improving patient survival**.  **[1717115_54548193252544e1abe35b0fc23f9ad9_0]** 
- Tempus will support the program by providing access to its **AI-enabled diagnostics** (including xE, xR, xF+, xM), its **CRO, Compass**, to manage trial operations, and its **data integration expertise**.  **[1717115_54548193252544e1abe35b0fc23f9ad9_0]**

Tempus AI Selected by ARPA-H for ADAPT Program

Tempus AI (TEM)